請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/79050完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳美如(Mei-Ru Chen) | |
| dc.contributor.author | Yu-Ruei Chang | en |
| dc.contributor.author | 張宇睿 | zh_TW |
| dc.date.accessioned | 2021-07-11T15:39:46Z | - |
| dc.date.available | 2025-08-17 | |
| dc.date.copyright | 2020-09-10 | |
| dc.date.issued | 2020 | |
| dc.date.submitted | 2020-08-17 | |
| dc.identifier.citation | Alwine, J.C. 2012. The human cytomegalovirus assembly compartment: a masterpiece of viral manipulation of cellular processes that facilitates assembly and egress. PLoS pathogens. 8. Baer, R., A. Bankier, M. Biggin, P. Deininger, P. Farrell, T. Gibson, G. Hatfull, G. Hudson, S. Satchwell, and C. Seguin. 1984. DNA sequence and expression of the B95-8 Epstein—Barr virus genome. Nature. 310:207-211. Bigalke, J.M., and E.E. Heldwein. 2016. Nuclear exodus: herpesviruses lead the way. Annual review of virology. 3:387-409. Bollard, C.M., C.M. Rooney, and H.E. Heslop. 2012. T-cell therapy in the treatment of post-transplant lymphoproliferative disease. Nature reviews Clinical oncology. 9:510. Bucks, M.A., K.J. O'Regan, M.A. Murphy, J.W. Wills, and R.J. Courtney. 2007. Herpes simplex virus type 1 tegument proteins VP1/2 and UL37 are associated with intranuclear capsids. Virology. 361:316-324. Chang, C.-W., C.-P. Lee, Y.-H. Huang, P.-W. Yang, J.-T. Wang, and M.-R. Chen. 2012. Epstein-Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins. Journal of virology. 86:8072-8085. Chee, M., G. Lawrence, and B. Barrell. 1989. Alpha-, beta-and gammaherpesviruses encode a putative phosphotransferase. Journal of General Virology. 70:1151-1160. Chiu, Y.-F., B. Sugden, P.-J. Chang, L.-W. Chen, Y.-J. Lin, Y.-C. Lan, C.-H. Lai, J.-Y. Liou, S.-T. Liu, and C.-H. Hung. 2012. Characterization and intracellular trafficking of Epstein-Barr virus BBLF1, a protein involved in virion maturation. Journal of virology. 86:9647-9655. Cockrell, S.K., M.E. Sanchez, A. Erazo, and F.L. Homa. 2009. Role of the UL25 protein in herpes simplex virus DNA encapsidation. Journal of virology. 83:47-57. Diefenbach, R.J. 2015. Conserved tegument protein complexes: Essential components in the assembly of herpesviruses. Virus research. 210:308-317. Durán, A.H., T.M. Greco, B. Vollmer, I.M. Cristea, K. Grünewald, and M. Topf. 2019. Protein interactions and consensus clustering analysis uncover insights into herpesvirus virion structure and function relationships. PLoS biology. 17:e3000316. Epstein, M.A. 1964. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1:702-703. Fixman, E.D., G.S. Hayward, and S.D. Hayward. 1995. Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. Journal of virology. 69:2998-3006. Gershburg, E., and J.S. Pagano. 2008. Conserved herpesvirus protein kinases. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics. 1784:203-212. Gonnella, R., A. Farina, R. Santarelli, S. Raffa, R. Feederle, R. Bei, M. Granato, A. Modesti, L. Frati, and H.-J. Delecluse. 2005. Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina. Journal of virology. 79:3713-3727. Grogan, E., H. Jenson, J. Countryman, L. Heston, L. Gradoville, and G. Miller. 1987. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. Proceedings of the National Academy of Sciences. 84:1332-1336. Hellberg, T., L. Paßvogel, K.S. Schulz, B.G. Klupp, and T.C. Mettenleiter. 2016. Nuclear egress of herpesviruses: the prototypic vesicular nucleocytoplasmic transport. In Advances in virus research. Vol. 94. Elsevier. 81-140. Henaff, D., G. Rémillard-Labrosse, S. Loret, and R. Lippé. 2013. Analysis of the early steps of herpes simplex virus 1 capsid tegumentation. Journal of virology. 87:4895-4906. Henderson, E., G. Miller, J. Robinson, and L. Heston. 1977. Efficiency of transformation of lymphocytes by Epstein-Barr virus. Virology. 76:152-163. Henle, G., W. Henle, and V. Diehl. 1968. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proceedings of the National Academy of Sciences of the United States of America. 59:94. Hsu, J.L., and S.L. Glaser. 2000. Epstein–Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Critical reviews in oncology/hematology. 34:27-53. Hudewentz, J., G. Bornkamm, and H. Zur Hausen. 1980. Effect of the diterpene ester TPA on Epstein-Barr virus antigen-and DNA synthesis in producer and nonproducer cell lines. Virology. 100:175-178. Hung, C.-H., Y.-F. Chiu, W.-H. Wang, L.-W. Chen, P.-J. Chang, T.-Y. Huang, Y.-J. Lin, W.-J. Tsai, and C.-C. Yang. 2019. Interaction Between BGLF2 and BBLF1 Is Required for the Efficient Production of Infectious Epstein–Barr Virus Particles. Frontiers in Microbiology. 10. Hung, C.-H., and S.-T. Liu. 1999. Characterization of the Epstein–Barr virus BALF2 promoter. Journal of general virology. 80:2747-2750. Johannsen, E., M. Luftig, M.R. Chase, S. Weicksel, E. Cahir-McFarland, D. Illanes, D. Sarracino, and E. Kieff. 2004. Proteins of purified Epstein-Barr virus. Proceedings of the National Academy of Sciences. 101:16286-16291. Johnson, D.C., and J.D. Baines. 2011. Herpesviruses remodel host membranes for virus egress. Nature Reviews Microbiology. 9:382-394. Küppers, R., I. Schwering, A. Bräuninger, K. Rajewsky, and M.L. Hansmann. 2002. Biology of Hodgkin's lymphoma. Annals of Oncology. 13:11-18. Kalejta, R.F. 2008. Tegument proteins of human cytomegalovirus. Microbiol. Mol. Biol. Rev. 72:249-265. Kawaguchi, Y., Y. Mori, and H. Kimura. 2018. Human Herpesviruses. Springer. Kelly, B.J., C. Fraefel, A.L. Cunningham, and R.J. Diefenbach. 2009. Functional roles of the tegument proteins of herpes simplex virus type 1. Virus research. 145:173-186. Klupp, B.G., H. Granzow, G.M. Keil, and T.C. Mettenleiter. 2006. The capsid-associated UL25 protein of the alphaherpesvirus pseudorabies virus is nonessential for cleavage and encapsidation of genomic DNA but is required for nuclear egress of capsids. Journal of Virology. 80:6235-6246. Lake, C.M., and L.M. Hutt-Fletcher. 2004. The Epstein–Barr virus BFRF1 and BFLF2 proteins interact and coexpression alters their cellular localization. Virology. 320:99-106. Lee, C.-P., P.-T. Liu, H.-N. Kung, M.-T. Su, H.-H. Chua, Y.-H. Chang, C.-W. Chang, C.-H. Tsai, F.-T. Liu, and M.-R. Chen. 2012. The ESCRT machinery is recruited by the viral BFRF1 protein to the nucleus-associated membrane for the maturation of Epstein-Barr Virus. PLoS Pathog. 8:e1002904. Lee, J.H., V. Vittone, E. Diefenbach, A.L. Cunningham, and R.J. Diefenbach. 2008. Identification of structural protein–protein interactions of herpes simplex virus type 1. Virology. 378:347-354. Lee, M.-A., M.E. Diamond, and J.L. Yates. 1999. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. Journal of virology. 73:2974-2982. Longnecker, R.M., E. Kieff, and J.I. Cohen. 2013. Epstein-barr virus. In Fields Virology: Sixth Edition. Wolters Kluwer Health Adis (ESP). Lu, J., S.-Y. Chen, H.-H. Chua, Y.-S. Liu, Y.-T. Huang, Y. Chang, J.-Y. Chen, T.-S. Sheen, and C.-H. Tsai. 2000. Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta. Journal of virology. 74:7391-7399. Luka, J., B. Kallin, and G. Klein. 1979. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology. 94:228-231. Mettenleiter, T.C., F. Müller, H. Granzow, and B.G. Klupp. 2013. The way out: what we know and do not know about herpesvirus nuclear egress. Cellular microbiology. 15:170-178. Miller, G., J.C. Niederman, and L.-L. Andrews. 1973. Prolonged oropharyngeal excretion of Epstein–Barr virus after infectious mononucleosis. New England Journal of Medicine. 288:229-232. Nakayama, S., T. Murata, K. Murayama, Y. Yasui, Y. Sato, A. Kudoh, S. Iwahori, H. Isomura, T. Kanda, and T. Tsurumi. 2009. Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein. Journal of Biological Chemistry. 284:21557-21568. Nanbo, A., T. Noda, and Y. Ohba. 2018. Epstein–Barr Virus Acquires Its Final Envelope on Intracellular Compartments With Golgi Markers. Frontiers in microbiology. 9:454. Old, L., E. Boyse, H. Oettgen, E. De Harven, G. Geering, B. Williamson, and P. Clifford. 1966. Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America. 56:1699. Park, J., D. Lee, T. Seo, J. Chung, and J. Choe. 2000. Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8) open reading frame 36 protein is a serine protein kinase. Journal of General Virology. 81:1067-1071. Pope, J., M. Horne, and W. Scott. 1968. Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes‐like virus. International journal of cancer. 3:857-866. Radtke, K., D. Kieneke, A. Wolfstein, K. Michael, W. Steffen, T. Scholz, A. Karger, and B. Sodeik. 2010. Plus-and minus-end directed microtubule motors bind simultaneously to herpes simplex virus capsids using different inner tegument structures. PLoS pathogens. 6. Ragoczy, T., L. Heston, and G. Miller. 1998. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. Journal of virology. 72:7978-7984. Rennekamp, A.J., P. Wang, and P.M. Lieberman. 2010. Evidence for DNA hairpin recognition by Zta at the Epstein-Barr virus origin of lytic replication. Journal of virology. 84:7073-7082. Rickinson, A., and E. Kieff. 2007. Epstein-Barr virus, p 2655–2700. Fields virology. 2:1310-1317. Sheaffer, A.K., W.W. Newcomb, M. Gao, D. Yu, S.K. Weller, J.C. Brown, and D.J. Tenney. 2001. Herpes simplex virus DNA cleavage and packaging proteins associate with the procapsid prior to its maturation. Journal of Virology. 75:687-698. Sixbey, J.W., J.G. Nedrud, N. Raab-Traub, R.A. Hanes, and J.S. Pagano. 1984. Epstein–Barr virus replication in oropharyngeal epithelial cells. New England Journal of Medicine. 310:1225-1230. Takada, K., K. Horinouchi, Y. Ono, T. Aya, T. Osato, M. Takahashi, and S. Hayasaka. 1991. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus genes. 5:147-156. Tokunaga, M., Y. Uemura, T. Tokudome, T. Ishidate, H. Masuda, E. Okazaki, K. Kaneko, S. Naoe, M. Ito, and A. Okamura. 1993. Epstein‐Barr virus related gastric cancer in Japan: a molecular patho‐epidemiological study. Pathology International. 43:574-581. van Gent, M., S.G. Braem, A. de Jong, N. Delagic, J.G. Peeters, I.G. Boer, P.N. Moynagh, E. Kremmer, E.J. Wiertz, and H. Ovaa. 2014. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling. PLoS pathogens. 10. Vittone, V., E. Diefenbach, D. Triffett, M.W. Douglas, A.L. Cunningham, and R.J. Diefenbach. 2005. Determination of interactions between tegument proteins of herpes simplex virus type 1. Journal of virology. 79:9566-9571. Wang, J.-T., P.-W. Yang, C.-P. Lee, C.-H. Han, C.-H. Tsai, and M.-R. Chen. 2005. Detection of Epstein–Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. Journal of general virology. 86:3215-3225. Young, L.S., L.F. Yap, and P.G. Murray. 2016. Epstein–Barr virus: more than 50 years old and still providing surprises. Nature Reviews Cancer. 16:789. Zur Hausen, H., H. Schulte-Holthausen, G. Klein, W. HENLE, G. HENLE, P. Clifford, and L. Santesson. 1970. Epstein–Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma: EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 228:1056-1058. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/79050 | - |
| dc.description.abstract | EB病毒屬於帶有外套膜的病毒,在其外殼及外套膜之間有一層被膜蛋白。被膜蛋白層的主要成分是一些來自病毒或是細胞的蛋白。被膜蛋白已被證實可以協助成熟病毒顆粒進行下一輪的感染,但是目前被膜蛋白被選擇並包裹進被膜蛋白層的機制還是未知的。先前的研究發現EB病毒單股DNA結合蛋白BALF2以及EB病毒蛋白激酶BGLF4會隨著病毒進入溶裂期晚期而部分分布在細胞質的近核區域中。此外,它們與EB病毒細胞質組裝區域的諸多蛋白質例如BBLF1和GM130有共位的情形。有趣的是,BALF2及BGLF4在病毒溶裂期都是在細胞核中執行功能,但他們最終都會被包裹至病毒的被膜蛋白層中。我們認為這些在細胞核中分布的蛋白可能會藉由與病毒的核外殼緊密相連而隨著核外殼一起被轉移至細胞質,為了探索這個可能性,我們建立了一個純化胞外病毒顆粒的實驗方式。純化出來的病毒顆粒會再藉由介面活性劑來去除外套膜後以0.1 M、0.5 M、1 M的KCl處理,再利用被膜蛋白對於外殼的親和性強弱對其區分。這些樣本以質譜儀的方式分析後來將這些被膜蛋白區分為外層被膜蛋白及內層被膜蛋白。我們想要對被膜蛋白之間的相互作用做深入的探討,先前的研究發現Flag-BALF2和HA-BVRF1可以在HEK-293T細胞中一起被免疫共沉澱下來,並且在NA細胞中BVRF1可以被BGLF4和BFRF1免疫共沉澱下來。因為BVRF1是和黏附於EB病毒外殼的蛋白且BFRF1是和外殼出核相關的蛋白,所以我們猜想BALF2以及BGLF4可能是藉由與BVRF1相互作用而被從細胞核帶到細胞質的。在本研究中,我們用免疫共沉澱法去觀察BALF2和BVRF1之間的交互作用。而為了進一步了解BALF2的哪些功能區域對於它從細胞核移動至細胞質是重要的,我們建構了帶有Flag以及各種功能區域缺失的BALF2質體。我們利用免疫螢光染色法以及免疫共沉澱法來探討這個問題。綜合以上,我們成功建立了純化病毒的方式,而為了對被膜蛋白被包裹的機制有更進一步的了解,被膜蛋白之間是藉由什麼功能區域相互作用的還需再進行確認。 | zh_TW |
| dc.description.abstract | Epstein-Barr virus (EBV) is an envelope virus. A tegument layer sit between its nucleocapsid and envelope. The components of the tegument layer are viral and cellular proteins. Tegument proteins are known to facilitate the second round infection, but how are they be selected and packaged into the tegument layer is still unclear. Previously, we found that EBV single-stranded DNA binding protein BALF2 and EBV protein kinase BGLF4 are partially localized to the cytoplasm juxtanuclear region during the late phase of lytic cycle. Besides, they also co-localized with some proteins contained in cytoplasmic assembly compartment including BBLF1 and GM130. Interestingly, both BALF2 and BGLF4 execute their function in the nucleus during lytic cycle and subsequently packaged into the tegument layer. We hypothesized that these nuclear distributed proteins are closely associated with the nucleocapsids in the nucleus and transported into cytoplasm. To investigate this possibility, we establish a protocol to purify extracellular viral particles. Detergent was used to disrupt the envelope of purified virus then 0.1 M, 0.5 M and 1 M of KCl were used to dissociate tegument proteins with different affinity to the capsids. The samples were then subjected to mass spectrometry to distinguish the inner and outer tegument proteins of EBV. In an attempt to map tegument protein-protein interaction, our previous co-immunoprecipitation data showing that Flag-BALF2 interact with HA-BVRF1 in HEK293T cells, and HA-BVRF1 form immunoprecipitation complex with BGLF4 and BFRF1 in NA cells. Because BVRF1 is a protein that associated with capsid and BFRF1 is a protein involved in nuclear egress, BALF2 and BGLF4 may be “brought” from the nucleus to the cytoplasm by the interaction with BVRF1. In this study, co-immunoprecipitation assay was used to examine the interaction between BALF2 and BVRF1. To map which functional domains are required for BALF2 to translocate from the nucleus to the cytoplasm, plasmids of truncated BALF2 with Flag tag were constructed. Immunofluorescence assay and co-immunoprecipitation assay were used to examine which domains are required for the translocation. Taken together, we established a virus purification protocol. The interaction domain mapping experiments still need to be confirmed for understanding the mechanism of tegumentation process. | en |
| dc.description.provenance | Made available in DSpace on 2021-07-11T15:39:46Z (GMT). No. of bitstreams: 1 U0001-1708202019075900.pdf: 2875093 bytes, checksum: 6d4ae593a8920015e3f323cc24d24509 (MD5) Previous issue date: 2020 | en |
| dc.description.tableofcontents | CONTENTS 口試委員審定書 致謝 中文摘要 ABSTRACT CONTENTS 1. INTRODUCTION……………………………………………………………....1 1.1 Epstein-Barr virus…………………………………………………………...1 1.1.1 The viral structure and genome of EBV…………………………………..1 1.1.2 The life cycle of EBV……………………………………………………..2 1.1.3 Nuclear egress of EBV……………………………………………………5 1.2 Herpesviral tegument proteins……………………………………………...7 1.2.1 Single-stranded DNA binding protein BALF2……………………………9 1.2.2 Capsid associated protein BVRF1……………………………………….11 1.2.3 Protein kinase BGLF4…………………………………………………...11 1.2.4 The interaction between EBV tegument proteins………………………..12 1.3 Aim of this study……………………………………………………………14 2. MATERIALS METHODS………………………………………………….16 2.1 Cell culture………………………………………………………………….16 2.2 Plasmids …………….………………………………………………………16 2.3 Cell transfection co-immunoprecipitation assay……………………….18 2.4 Western blot analysis……………………………………………………….19 2.5 Immunofluorescence assay (IFA)………………………………………….21 2.6 Virion purification………………………………………………………….21 2.6.1 Purification of extracellular virus particles……………………………...21 2.6.2 Removal of viral envelope outer tegument proteins and for mass spectrometry……………………………….……………………………24 2.6.3 Purification of nucleocapsids from nuclear fraction…………………......27 2.7 EBV extracellular DNA extraction………………………………………...28 2.8 Quantitative polymerase chain reaction (Q-PCR) analysis………………28 3. RESULTS………………………………………………………………………30 3.1 Detection of EBV tegument proteins in the viral particles purified from EBV positive Akata cells……………………………………………………30 3.2 Purification of nucleocapsids from EBV positive Akata cells…………….32 3.3 Detection of tegument proteins BALF2, BVRF1, and BGLF4 in the viral particles purified from B95.8 cells…………………………………………33 3.4 Characterization of EBV tegument proteins BALF2, BGLF4, BVRF1 in B95.8 derived viral particles……………………………………………….35 3.5 Flag-BALF2 interacts with HA-BVRF1 in HeLa cells……………………37 3.6 Construction of Flag-tagged domain deletion of BALF2 plasmids……....37 3.7 Examination of which functional domain is required for BALF2 to interact with BVRF1…………………………………………………………………38 3.8 Examination of which functional domain is required for BALF2 to translocated from the nucleus to the cytoplasmic assembly compartment39 4. DISSCUSSION………………………………………………………………...41 5. FIGURES………………………………………………………………………49 Fig.1. Hypothetic model of the translocation process of tegument proteins BALF2 and BGLF4……………………………………………………………………...49 Fig.2. Akata cells secrete the maximal EBV particles at 96 hours post induction………………………………………………………………………...50 Fig.3. Viral proteins were detected in the extracellular EBV particles purified from EBV positive Akata cells.……………………………………………………….51 Fig.4. Purification of nucleocapsids from EBV positive Akata cells ………………52 Fig.5. EBV lytic cycle in B95.8 cells induced by TPA/SB…………………………53 Fig.6. Detection of EBV tegument proteins and viral genome in extracellular viral particles from B95.8 purified by small scale purification………………...…….54 Fig.7. Detection of EBV tegument proteins and viral genome in extracellular viral particles from B95.8 cells purified by large scale purification.………………….55 Fig.8. Validation of EBV copy number by qPCR in purified and outer tegument dissociated virions................................................................................................56 Fig.9. HA-BVRF1 was co-immunoprecipitated by Flag-BALF2 in HeLa cells…...................................................................................................................58 Fig.10. Protein expression of truncated Flag-BALF2 in HeLa cells and NA cells.……………………………………………………………………………..59 Fig.11. Mapping of functional domains required for BALF2 to interact with BVRF1.…………………………………………………………………............60 Fig.12. Localization of BALF2 and BVRF1 in NA cells after Rta induction for 48 hours.……………………………………………………………………………62 Fig.13. Mapping of functional domains required for BALF2 to translocate from the nucleus to the cytoplasmic assembly compartment……………………………...63 6. SUPPLEMENTARY DATA…………………………………………………...65 Table. S1. BALF2, BVRF1, and BGLF4 are included in the EBV virion tegument layer component…...……………………………………………………………65 Figure.S1. BALF2 and HA-BVRF1 was co-immunoprecipitated reciprocally in transiently transfected HEK293T cells………………………………………….66 Fig.S2. HA-BVRF1 was co-immunoprecipitated by BFRF1 and BGLF4 in EBV reactivated NA cell………………………………………………………………67 7. REFERENCES…………………………………………………………….......68 | |
| dc.language.iso | en | |
| dc.subject | BALF2 | zh_TW |
| dc.subject | 被膜蛋白 | zh_TW |
| dc.subject | EB病毒 | zh_TW |
| dc.subject | EBV | en |
| dc.subject | Tegument protein | en |
| dc.subject | BALF2 | en |
| dc.title | EB病毒單股DNA結合蛋白BALF2被包裹入被膜蛋白層的過程之探討 | zh_TW |
| dc.title | The investigation of the tegumentation process of EBV single stranded DNA binding protein BALF2 | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 108-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 張麗冠(Li-Kwan Chang),楊宏志(Hung-Chih Yang),林妙霞(Miao-Hsia Lin) | |
| dc.subject.keyword | EB病毒,被膜蛋白,BALF2, | zh_TW |
| dc.subject.keyword | EBV,Tegument protein,BALF2, | en |
| dc.relation.page | 72 | |
| dc.identifier.doi | 10.6342/NTU202003838 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2020-08-18 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 微生物學研究所 | zh_TW |
| dc.date.embargo-lift | 2025-08-17 | - |
| 顯示於系所單位: | 微生物學科所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| U0001-1708202019075900.pdf 未授權公開取用 | 2.81 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
